Qube Research & Technologies Ltd - IMMUNOCORE HLDGS PLC ownership

IMMUNOCORE HLDGS PLC's ticker is IMCR and the CUSIP is 45258D105. A total of 110 filers reported holding IMMUNOCORE HLDGS PLC in Q1 2023. The put-call ratio across all filers is 0.18 and the average weighting 0.6%.

Quarter-by-quarter ownership
Qube Research & Technologies Ltd ownership history of IMMUNOCORE HLDGS PLC
ValueSharesWeighting
Q2 2024$8,534,146
+42.7%
251,819
+173.7%
0.01%
+44.4%
Q1 2024$5,979,805
+50.0%
91,997
+57.7%
0.01%
+12.5%
Q4 2023$3,986,062
-38.7%
58,344
-53.4%
0.01%
-52.9%
Q3 2023$6,497,828
+74.9%
125,199
+102.0%
0.02%
+21.4%
Q2 2023$3,715,541
-51.1%
61,967
-59.7%
0.01%
-57.6%
Q1 2023$7,604,317
-19.5%
153,809
-7.0%
0.03%
-35.3%
Q4 2022$9,443,088165,4650.05%
Other shareholders
IMMUNOCORE HLDGS PLC shareholders Q1 2023
NameSharesValueWeighting ↓
Bill & Melinda Gates Foundation 576,923$34,592,30327.53%
RTW INVESTMENTS, LP 6,029,633$361,536,7956.88%
Paradigm Biocapital Advisors LP 1,270,124$76,156,6355.88%
Rock Springs Capital Management LP 3,028,410$181,583,4644.32%
Logos Global Management LP 500,000$29,980,0004.08%
TANG CAPITAL MANAGEMENT LLC 405,600$24,319,7763.58%
GREAT POINT PARTNERS LLC 297,082$17,813,0373.49%
Eschler Asset Management LLP 34,000$2,038,6402.89%
COWEN AND COMPANY, LLC 460,036$27,583,7582.29%
HighVista Strategies LLC 44,094$2,643,8761.21%
View complete list of IMMUNOCORE HLDGS PLC shareholders